Updated on: Apr 02, 2014

Sharon Bio-Medicine Ltd has informed BSE that: "Sharon has completed expansion in its 3 manufacturing facilities. The total investment in expansion has been incurred to the tune nearly Rs. 125 Crores. In Dehradun Formulation plant, the expanded expenditure has been app. Rs. 85/- Crores whereas capacity of the plant has been increased more than double. Similarly, other plants’ capacity has been added between 30% to 50%. The commercial production in Sharon two expanded plants at Taloja near Navi Mumbai have already been started and Dehradun Formulation expanded facility will start production from June, 2014."

Source : BSE - >www.bseindia.com

Published on April 02, 2014

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like

Recommended for you